BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21953756)

  • 1. In-stent restenosis: while not exactly about smoking, it so often is about smoking.
    Butman S
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):609-10. PubMed ID: 21953756
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery.
    Trentmann J; Charalambous N; Djawanscher M; Schäfer J-; Jahnke T
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):551-60. PubMed ID: 20671639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular therapy of lower extremity arterial occlusive disease: are advanced generation devices worth the cost?
    Criado FJ
    J Mal Vasc; 1994; 19 Suppl A():178-82. PubMed ID: 8158081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the "cold" laser simply need a cover up?
    Butman SM
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):860. PubMed ID: 23097293
    [No Abstract]   [Full Text] [Related]  

  • 5. Endovascular treatment of femoro-popliteal obstructive disease.
    Rigatelli G; Cardaioli P; Giordan M
    Minerva Cardioangiol; 2007 Feb; 55(1):125-32. PubMed ID: 17287687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of DES in peripheral in-stent restenosis.
    Zeller T; Macharzina R; Tepe G
    J Cardiovasc Surg (Torino); 2010 Aug; 51(4):561-5. PubMed ID: 20671640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral artery disease: Laser light show--targeting in-stent restenosis in peripheral arteries with excimer laser atherectomy.
    Geach T
    Nat Rev Cardiol; 2015 Feb; 12(2):63. PubMed ID: 25560374
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug coated ballons for femoro-popliteal interventions.
    Tamburrini L; Vosseler M; Espinola-Klein C
    Vasa; 2018 Jan; 47(1):68-69. PubMed ID: 29281955
    [No Abstract]   [Full Text] [Related]  

  • 9. The pitfalls of femoropopliteal stenting trials.
    Mwipatayi BP; Leong BD; Hockley J; Vijayan V
    J Endovasc Ther; 2012 Oct; 19(5):596-8. PubMed ID: 23046323
    [No Abstract]   [Full Text] [Related]  

  • 10. Endovascular interventions in iliac and infrainguinal occlusive artery disease.
    Ruef J; Hofmann M; Haase J
    J Interv Cardiol; 2004 Dec; 17(6):427-35. PubMed ID: 15546296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occlusion of peripheral aneurysms by arterial stent implantation in inoperable patients--a methodologic alternative?].
    Althoff M; Schulte E; Ranft J; Rudofsky G
    Vasa Suppl; 1992; 35():184-5. PubMed ID: 1481039
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endovascular therapy options in femoro-popliteal PAD].
    Brechtel K
    Rofo; 2010 Sep; 182(9):755-63. PubMed ID: 20603777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year outcomes of the RESILIENT trial: are they enough to support a primary stenting policy?
    Davies MG
    J Endovasc Ther; 2012 Feb; 19(1):10-1. PubMed ID: 22313194
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary: resuscitation of endovascular brachytherapy owing to improved logistics.
    Minar E
    J Endovasc Ther; 2012 Aug; 19(4):476-9. PubMed ID: 22891825
    [No Abstract]   [Full Text] [Related]  

  • 15. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of mechanical atherectomy and drug-eluting balloons for femoropopliteal in-stent restenosis.
    Beschorner U; Zeller T
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):347-9. PubMed ID: 24755703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug-Coated Balloons and Stents for the Treatment of Femoro-Popliteal Lesions].
    Ito WD
    Dtsch Med Wochenschr; 2017 Aug; 142(15):1093-1096. PubMed ID: 28763816
    [No Abstract]   [Full Text] [Related]  

  • 18. [Outcome of endovascular therapy of iliac, superficial femoral and popliteal arteries in 136 patients].
    Jiang XJ; Zhang HM; Yang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):1015-9. PubMed ID: 18269822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and long-term outcome of Silverhawk assisted atherectomy for femoro-popliteal lesions according the TASC II classification: a single-center experience.
    Sixt S; Rastan A; Beschorner U; Noory E; Schwarzwälder U; Bürgelin K; Schwarz T; Müller C; Hauk M; Brantner R; Möhrle C; Linnemann B; Macharzina R; Neumann FJ; Zeller T
    Vasa; 2010 Aug; 39(3):229-36. PubMed ID: 20737381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital outcomes and cost comparison of femoropopliteal reopening strategies.
    Safley DM; Lindsey JB; Robertus K; House JA; Mahoney E; Allen KB; Cohen DJ
    Cardiovasc Revasc Med; 2011; 12(5):292-8. PubMed ID: 21273148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.